SBL
PRAH

Sargent Bickham Lagudis’s PRA Health Sciences, Inc. PRAH Stock Holding History

Sargent Bickham Lagudis’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100
Closed -$10K – 801
2019
Q2 		$10K Hold
100
– – ﹤0.01% 597
2019
Q1 		$11K Hold
100
– – ﹤0.01% 603
2018
Q4 		$9K Hold
100
– – ﹤0.01% 604
2018
Q3 		$11K Hold
100
– – ﹤0.01% 601
2018
Q2 		$9K Hold
100
– – ﹤0.01% 610
2018
Q1 		$8K Hold
100
– – ﹤0.01% 624
2017
Q4 		$9K Buy
+100
New +$8.32K ﹤0.01% 631

Other funds holding PRAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sargent Bickham Lagudis's PRAH Position: Q3 2019 in Review

Sargent Bickham Lagudis sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 100 shares — an estimated $10K sold.

Sargent Bickham Lagudis first reported a position in PRAH in Q4 2017 and held it in 7 quarters. The position peaked at $11K in Q1 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • Sargent Bickham Lagudis reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 100 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $10K.
  • Sargent Bickham Lagudis first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 7 quarters.
  • Sargent Bickham Lagudis's PRA Health Sciences, Inc. position peaked at $11K in Q1 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2019, filed 14 Sep 2021.